Over 650 Total Lots Up For Auction at Three Locations - TX 05/06, NJ 05/08, WA 05/09

Bittium exhibits high-tech products and solutions for cardiology and neurology at Medica

Press releases may be edited for formatting or style | November 18, 2019 Cardiology

Bittium BrainStatus™ is a wireless compact EEG amplifier, which is used together with a disposable easy and quick to wear Bittium BrainStatus electrode headband for example to diagnose epileptic seizures and brain stroke. Bittium BrainStatus enables quick measurement in field conditions as well as in hospitals, thus making the treatment process of the patient faster. Bittium BrainStatus can be used for wireless real-time remote EEG monitoring or data can be recorded to the device memory.

Bittium BrainStatus™ with Cerenion C-Trend is the world’s first practical method for measuring the brain function of intensive care patients. C-Trend technology aims to reveal the status of the brain as one simple and easy to interpret score. Bittium BrainStatus measures and monitors the EEG signal and C-Trend interprets the signal to a simple score by using advanced machine learning algorithms and artificial intelligence.

Bittium NeurOne™ is one of the quickest and most accurate EEG measuring devices in the world designed for clinical and research use. Bittium NeurOne system enables fully synchronized group measuring of up to 30 persons simultaneously for example in different types of psychological studies. The solution is optimized for use with transcranial magnetic stimulators (TMS-EEG), with optional possibility to use it during magnetic resonance imaging procedures (fMRI-EEG).

Bittium’s products and solutions are exhibited at stand 9D12.


Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2018 were EUR 62.8 million and operating profit was EUR 2.8 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Back to HCB News

You Must Be Logged In To Post A Comment